Because it is a precursor, it allows your body to regulate its own production of glutathione
Currently, seven AOMs are approved by both the Food and Drug Administration (FDA) and European Medicines Agency (EMA) -liraglutide, semaglutide, tirzepatide, orlistat, naltrexone/bupropion, setmelanotide, and metreleptin- while two additional agents (phentermine and phentermine/topiramate) are FDA-approved only
References consulted in writing this post: Alexandra M Bodnaruc 1, Denis Prudhomme 2, Rosanne Blanchet 3, Isabelle Giroux 4 Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review
In other investigated variables, extending supplementation duration was ineffective in the overall results
Compounded medications offer flexibility and affordability, but can come with oversight challenges